Get started
Author

Aleksandra M. Stanczak

Observed names: A. Stanczak, A. Stańczak, Aleksandra Stanczak, Aleksandra Stańczak
OpenAlex ID: A5043905816
Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
2014 · Lubomir Bodnar, Aleksandra Stanczak, et al. · Journal of Ovarian Research · 83
PDF
Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
2011 · Aleksandra Stanczak, Rafal Stec, et al. · Pathology & Oncology Research · 80
PDF
Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
2014 · Paulina Grygielewicz, Barbara Dymek, et al. · Gastric Cancer · 70
PDF
Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1–3)
2020 · Abdellah Yamani, Daria Zdżalik-Bielecka, et al. · European Journal of Medicinal Chemistry · 49
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
2021 · Kamila Kitowska, Monika Gorska-Arcisz, et al. · Frontiers in Oncology · 30
PDF
Sample Preparation for Multi‐Omics Analysis: Considerations and Guidance for Identifying the Ideal Workflow
2025 · Breyer Woodland, Luke A. Farrell, et al. · PROTEOMICS · 26
PDF
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives
2022 · Mariola Stypik, Stanisław Michałek, et al. · Pharmaceuticals · 11
PDF
Adipose-Derived Stem Cells Spontaneously Express Neural Markers When Grown in a PEG-Based 3D Matrix
2023 · Neus Gomila Pelegri, Aleksandra M. Stanczak, et al. · International Journal of Molecular Sciences · 10
PDF
FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
2022 · Joanna Moes-Sosnowska, Monika Skupinska, et al. · International Journal of Molecular Sciences · 10
PDF
p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
2021 · Izabela Zarczynska, Monika Gorska-Arcisz, et al. · Cells · 10
PDF
Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer
2024 · Delfina Popiel, Aleksandra Stańczak, et al. · Frontiers in Oncology · 7
Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators
2015 · Maria Mazur, Anna Bujak, et al. · Analytical Biochemistry · 7
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives
2022 · Mariola Stypik, Marcin Zagozda, et al. · Pharmaceuticals · 4
PDF
Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors
2015 · Pawel Gunerka, Barbara Dymek, et al. · European Journal of Pharmacology · 4
Identification of pyrrolo[2,3-d]pyrimidine-based dual MERTK and FLT3 inhibitor: Hit-to-lead, machine learning, modeling, synthesis, and biological evaluation
2026 · Abdellah Yamani, Paweł Maliszewski, et al. · European Journal of Pharmaceutical Sciences · 2
550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers
2020 · D. Popiel, A. Mikołajczyk, et al. · Annals of Oncology · 2
The role of FGFR2 amplification and expression in patients with advanced or metastatic gastric cancer receiving fluoropyrimidine-based chemotherapy
2018 · M.M. Skupinska, M. Jesiotr, et al. · Annals of Oncology · 2
712P Analysis of fibroblast growth factor receptor 3 aberrations in bladder cancer, for enabling personalized and effective therapy based on FGFR inhibitor
2021 · R. Sosnowski, D. Popiel, et al. · Annals of Oncology · 1
1409P Comparing different methods of FGFR1 aberrations analysis in squamous cell lung cancer (SqCLC) targeted therapy
2020 · M.M. Skupinska, T. Obtulowicz, et al. · Annals of Oncology · 1
Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
2014 · Anna Bujak, Patrycja Nejman-Gryz, et al. · European Respiratory Journal · 1
FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC)
2021 · Joanna Moes-Sosnowska, Adriana Rozy, et al. · European Respiratory Journal
P35.08 RNA-Based Gene Alteration and Expression Analysis in Sq-NSCLC with known FGFR1 Amplification and Protein Expression Status
2021 · J. Moes-Sosnowska, A. Rozy, et al. · Journal of Thoracic Oncology
PDF
Molecular profiling of Sq-NSCLC with enhanced FGFR1-4 and MET gene expression – NGS pilot study
2020 · Joanna Moes-Sosnowska, Ewa Szczepulska-Wojcik, et al. · European Respiratory Journal
In research of molecular mechanism of gastric cancer cell response to FGFR inhibitor
2018 · Dima Antoun, Kamila Kitowska, et al. · Acta Biochimica Polonica
Analiza ekspresji genu FGFR2 u chorych na raka żołądka leczonych chemioterapią pierwszej linii opartą na fluoropirymidynie
2018 · Marzena Jesiotr, Monika Supińska, et al.
Works count: 31
Citation count: 410
H-index: 10
I10-index: 10
Year
Topic
Type